반응식
[C:1]([O:5][C:6]([NH:8][CH2:9][CH2:10][CH2:11][CH2:12][C:13]([OH:15])=O)=[O:7])([CH3:4])([CH3:3])[CH3:2].[CH2:16]([O:23][C:24](=[O:28])[CH2:25][CH2:26][NH2:27])[C:17]1[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=1>>[CH2:16]([O:23][C:24](=[O:28])[CH2:25][CH2:26][NH:27][C:13](=[O:15])[CH2:12][CH2:11][CH2:10][CH2:9][NH:8][C:6]([O:5][C:1]([CH3:2])([CH3:3])[CH3:4])=[O:7])[C:17]1[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=1참가 물질
3
실험 절차
5-(1-t-butoxyformamido)valeric acid was coupled with β-alanine benzyl ester to give N-[5-(1-t-butoxyformamido)valeryl]-β-alanine benzyl ester, m.p. 69°-70° C.
출처 및 근거
- ORD 기록
- ord-92a4012d620a41209d3bbf85f297f9ba
- 출처 데이터셋
- uspto-grants-1993_12
- 특허 번호
- US05273982
연결된 노트
불러오는 중…